Medicure (MCUJF) Change in Accured Expenses (2009 - 2026)
Medicure (MCUJF) posted quarterly Change in Accured Expenses of -$604511.5 for Q1 2026, down 309.01% year-over-year from $289220.3 in Q1 2025, and down 128.33% quarter-over-quarter from $2.1 million in Q4 2025.
Medicure (MCUJF) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Medicure's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$604511.5 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 309.01% year-over-year to -$604511.5; the TTM figure through Mar 2026 stood at $1.2 million (up 1019.36% YoY), while the FY2025 annual figure was $2.1 million, up 684.77% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$604511.5, down from $2.1 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.1 million in Q4 2025, with the low at -$663235.5 in Q3 2022.
- The 5-year median for Change in Accured Expenses is -$88351.8 (2024), against an average of $85097.2.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses surged 987.24% in 2025, then slumped 309.01% in 2026.
- Medicure's Change in Accured Expenses stood at -$663235.5 in 2022, then soared by 196.57% to $640515.0 in 2023, then plunged by 137.55% to -$240525.3 in 2024, then soared by 987.24% to $2.1 million in 2025, then slumped by 128.33% to -$604511.5 in 2026.
- Business Quant data shows MCUJF's Change in Accured Expenses at -$604511.5 in Q1 2026, $2.1 million in Q4 2025, and -$467952.9 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | -604,511.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -604,511.52 |
| Mar 31, 2026 | -604,511.52 |
| Dec 31, 2025 | 2.13 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | -467,952.94 |
| Sep 30, 2025 | -467,952.94 |
| Jun 30, 2025 | 145,064.21 |
| Jun 30, 2025 | 145,064.21 |
| Mar 31, 2025 | 289,220.34 |
| Mar 31, 2025 | 289,220.34 |
| Dec 31, 2024 | -240,525.31 |
| Dec 31, 2024 | -240,525.31 |
| Sep 30, 2024 | -592,307.16 |
| Sep 30, 2024 | -592,307.16 |
| Jun 30, 2024 | 412,363.27 |
| Jun 30, 2024 | 412,363.27 |
| Mar 31, 2024 | 63,821.74 |
| Mar 31, 2024 | 63,821.74 |
| Dec 31, 2023 | 640,514.98 |
| Dec 31, 2023 | 640,514.98 |